Obesity Does Not Modulate the Glycometabolic Benefit of Insoluble Cereal Fibre in Subjects with Prediabetes—A Stratified Post Hoc Analysis of the Optimal Fibre Trial (OptiFiT)
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Obesity does not modulate the glycometabolic benefit of insoluble cereal fibre in subjects with prediabetes—a stratified post hoc analysis of the Optimal Fibre Trial (OptiFiT). Background: OptiFiT demonstrated the beneficial effect of insoluble oat fibres on dysglycemia in prediabetes. Recent analyses of OptiFiT and other randomised controlled trials (RCTs) indicated that this effect might be specific for the subgroup of patients with impaired fasting glucose (IFG). As subjects with IFG are more often obese, there is a need to clarify if the effect modulation is actually driven by glycemic state or body mass index (BMI). Aim: We conducted a stratified post hoc analysis of OptiFiT based on the presence or absence of obesity. Methods: 180 Caucasian participants with impaired glucose tolerance (IGT) were randomised in a double-blinded fashion to either twice-a-day fibre or placebo supplementation for 2 years (n = 89 and 91, respectively). Once a year, they underwent fasting blood sampling, an oral glucose tolerance test (oGTT) and full anthropometry. At baseline, out of 136 subjects who completed the first year of intervention, 87 (62%) were classified as OBESE (BMI >30) and 49 subjects were NONOBESE. We performed a stratified per-protocol analysis of the primary glycemic and secondary metabolic effects attributable to dietary fibre supplementation after 1 year of intervention. Results: Neither the NONOBESE nor the OBESE subgroup showed significant differences between the respective fibre and placebo groups in metabolic, anthropometric or inflammatory outcomes. None of the four subgroups showed a significant improvement in either fasting glucose or glycated haemoglobin (HbA1c) after 1 year of intervention and only OBESE fibre subjects improved 2 h glucose. Within the NONOBESE stratum, there were no significant differences in the change of primary or secondary metabolic parameters between the fibre and placebo arms. We found a significant interaction effect for leukocyte count (time × supplement × obesity status). Within the OBESE stratum, leukocyte count and gamma-glutamyl transferase (GGT) levels decreased more in the fibre group compared with placebo (adjusted for change in body weight). Comparison of both fibre groups revealed that OBESE subjects had a significantly stronger benefit with respect to leukocyte count and fasting C-peptide levels than NONOBESE participants. Only the effect on leukocyte count survived correction for multiple comparisons. In contrast, under placebo conditions, NONOBESE subjects managed to decrease their body fat content significantly more than OBESE ones. Intention-to-treat (ITT) analysis resulted in similar outcomes. Conclusions: The state of obesity does not relevantly modulate the beneficial effect of cereal fibre on major glycometabolic parameters by fibre supplementation, but leukocyte levels may be affected. Hence, BMI is not a suitable parameter to stratify this cohort with respect to diabetes risk or responsiveness to cereal fibre, but obesity needs to be accounted for when assessing anti-inflammatory effects of fibre treatments. Targeted diabetes prevention should focus on the actual metabolic state rather than on mere obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is much evidence in the literature to support an association between dietary fibre intake and insulin sensitivity [30,31,32,33,34,35].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a further study, Kabisch and colleagues demonstrated an interventional interaction effect of dietary fibre supplementation on inflammation [35]. Interestingly, whilst the effect size for the anti-hyperglycaemic properties of insoluble dietary fibre seemed to depend mainly on the prevailing metabolic state, the anti-inflammatory effect of the particular supplement used in this study related prim”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, in our own interventional OptiFiT study, the control group was encouraged to eat more fibre with little success [34,35].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 4×
“Abbreviations ALAT alanine-amino transferase ASAT aspartate-amino transferase AUC area under the curve BCAA branched-chain amino acid BIA bioelectric impedance analysis CRP C-reactive protein EPAQ European Physical Activity Questionnaire FLI fatty liver index GGT gamma-glutamyl transferase GLP-1 glucagon-like peptide…”
MethodInfluentialToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042 · cited 3×
“Abbreviations ALAT alanine-amino transferase ASAT aspartate-amino transferase AUC area under the curve BCAA branched-chain amino acid BIA bioelectric impedance analysis CRP C-reactive protein EPAQ European Physical Activity Questionnaire FLI fatty liver index GGT gamma-glutamyl transferase GLP-1 glucagon-like peptide…”
MethodInfluentialAhlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799 · cited 1×
“Advice for increased fibre load by the daily diet has turned out to be mostly fruitless in the OptiFiT subjects, highlighting the need for fibre supplementation or fortified food products [38].”
BackgroundRisk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Sattar, N., Eliasson, B., Svensson, A.-M., Zethelius, B., Miftaraj, M., McGuire, D. K., Rosengren, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800256 · Cited by 1,475
Cited by
The Health Benefits of Dietary Fibre
Barber, T. M., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2020) · Nutrients · doi:10.3390/nu12103209 · Cited by 892
“In a further study, Kabisch and colleagues demonstrated an interventional interaction effect of dietary fibre supplementation on inflammation [35].”
BackgroundInfluentialSelf-citationBarber, T. M., Kyrou, I., Randeva, H. S., & Weickert, M. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020546 · Cited by 169
“However, despite these compelling data that support the beneficial effects of dietary fibre intake on insulin sensitivity, there were relatively few controlled studies (with a notable exception [93] that reported on the longer-term (>12 months) metabolic effects of dietary fibre intake [96].”
BackgroundSelf-citationThe Low-Carbohydrate Diet: Short-Term Metabolic Efficacy Versus Longer-Term Limitations
Barber, T. M., Hanson, P., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2021) · Nutrients · doi:10.3390/nu13041187 · Cited by 109
Self-citationThe Role of Oat Nutrients in the Immune System: A Narrative Review
Chen, O., Mah, E., Dioum, E. M., Marwaha, A., Shanmugam, S., Malleshi, N. G., Sudha, V., Gayathri, R., Unnikrishnan, R., Anjana, R. M., et al. (2021) · Nutrients · doi:10.3390/nu13041048 · Cited by 82
“…oat insoluble fibers containing 70 wt% cellulose, 25 wt% hemicellulose and 3–5 wt% lignin for two years did not affect CRP and IL-18 as compared to placebo even though it improved glycemic metabolism in people with impaired fasting glucose [72,73] (Honsek et al., 2018; Kabisch et al., 2019).”
BackgroundMethodYu, B., Tang, Q., Fu, C., Regenstein, J. M., Huang, J., & Wang, L. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.133834 · Cited by 71
Metadata
- Authors
- Kabisch, S., Meyer, N. M. T., Honsek, C., Gerbracht, C., Dambeck, U., Kemper, M., Osterhoff, M. A., Birkenfeld, A. L., Arafat, A. M., Weickert, M. O., & Pfeiffer, A. F. H.
- Affiliations
- Helmholtz Munich (DE)
- German Institute of Human Nutrition (DE)
- University Hospital Coventry (GB)
- Corresponding author
- Kabisch, Stefan
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-11-11
- Volume
- 11
- Issue
- 11
- Pages
- 2726
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6893443
- OpenAlex
- W2987977594
- Cited by
- 20
- References
- 51
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 7 · 2020: 1 · 2019: 1
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Site cant be reached (submittedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- Funders
- Diabetes-Stiftung (Grant No. 232/11/08)
- J. Rettenmaier & Soehne, Holzmühle, Germany (Company) (fiber supplement)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- prediabetes, obesity, insoluble dietary fiber, oat fiber, impaired fasting glucose, body mass index, white blood cell count, gamma-glutamyl transferase, C-peptide, HbA1c, fasting blood glucose, dysglycemia, inflammation, dietary fiber supplementation, subgroup analysis, weight change, insulin resistance, gut microbiota, intestinal permeability
- MeSH terms
- Aged, Algorithms, Blood Glucose, Edible Grain, Diabetes Mellitus, Type 2, Diet, Dietary Fiber, Female, Humans, Insulin Resistance, Male, Middle Aged, Obesity, Prediabetic State, Body Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity Does Not Modulate the Glycometabolic Benefit of Insoluble Cereal Fibre in Subjects with Prediabetes—A Stratified Post Hoc Analysis of the Optimal Fibre Trial (OptiFiT). https://app.cochat.ai/papers/10.3390/nu11112726
- The paper
- Kabisch, S., Meyer, N. M. T., Honsek, C., Gerbracht, C., Dambeck, U., Kemper, M., Osterhoff, M. A., Birkenfeld, A. L., Arafat, A. M., Weickert, M. O., & Pfeiffer, A. F. H. (2019). Obesity Does Not Modulate the Glycometabolic Benefit of Insoluble Cereal Fibre in Subjects with Prediabetes—A Stratified Post Hoc Analysis of the Optimal Fibre Trial (OptiFiT). Nutrients. https://doi.org/10.3390/nu11112726
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.